135 related articles for article (PubMed ID: 3492571)
21. Antibody affinity in infants after immunization with conjugated capsular polysaccharide from Haemophilus influenzae type b.
Hetherington SV; Rutkowski AF
J Infect Dis; 1990 Nov; 162(5):1185-8. PubMed ID: 2230242
[TBL] [Abstract][Full Text] [Related]
22. Dose-related immunogenicity of Haemophilus influenzae type b capsular polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine.
Wong VK; Quagliata R; Adler R; Kim KS
Am J Dis Child; 1991 Jul; 145(7):742-5. PubMed ID: 2058604
[TBL] [Abstract][Full Text] [Related]
23. Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation.
Sood SK; Daum RS
Pediatrics; 1990 Apr; 85(4 Pt 2):698-704. PubMed ID: 2107522
[TBL] [Abstract][Full Text] [Related]
24. Isotype distribution and bactericidal activity of antibodies after immunization with Haemophilus influenzae type b vaccines at 18-24 months of age.
Käyhty H; Mäkelä O; Eskola J; Saarinen L; Seppälä I
J Infect Dis; 1988 Nov; 158(5):973-82. PubMed ID: 3053931
[TBL] [Abstract][Full Text] [Related]
25. Immunogenicity and reactogenicity of four Haemophilus influenzae type b capsular polysaccharide vaccines in Finnish 24-month-old children.
Käyhty H; Peltola H; Eskola J
Pediatr Infect Dis J; 1988 Aug; 7(8):574-7. PubMed ID: 3050853
[TBL] [Abstract][Full Text] [Related]
26. Functional activity of different IgG subclass antibodies against type b capsular polysaccharide of Haemophilus influenzae.
Weinberg GA; Granoff DM; Nahm MH; Shackelford PG
J Immunol; 1986 Jun; 136(11):4232-6. PubMed ID: 3486228
[TBL] [Abstract][Full Text] [Related]
27. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate): immunogenicity and safety at various doses.
Yogev R; Arditi M; Chadwick EG; Amer MD; Sroka PA
Pediatrics; 1990 Apr; 85(4 Pt 2):690-3. PubMed ID: 2107520
[TBL] [Abstract][Full Text] [Related]
28. Capsular polysaccharide of Haemophilus influenzae type b as a vaccine.
Parke JC
Pediatr Infect Dis J; 1987 Aug; 6(8):795-8. PubMed ID: 3313244
[TBL] [Abstract][Full Text] [Related]
29. Functional activities of human antibody induced by the capsular polysaccharide or polysaccharide-conjugate vaccines against Haemophilus influenzae type b.
Deveikis A; Ward J; Kim KS
Vaccine; 1988 Feb; 6(1):14-8. PubMed ID: 3258459
[TBL] [Abstract][Full Text] [Related]
30. Prevention of Haemophilus influenzae type b infections in Apache and Navajo children.
Santosham M; Rivin B; Wolff M; Reid R; Newcomer W; Letson GW; Almeido-Hill J; Thompson C; Siber GR
J Infect Dis; 1992 Jun; 165 Suppl 1():S144-51. PubMed ID: 1588150
[TBL] [Abstract][Full Text] [Related]
31. National Advisory Committee on Immunization (NACI). Statement on Haemophilus influenzae type B conjugate vaccines for use in infants and children.
Can Commun Dis Rep; 1992 Dec; 18(23):169-76. PubMed ID: 1291012
[TBL] [Abstract][Full Text] [Related]
32. A rapid and sensitive chemiluminescence assay for evaluation of functional opsonic activity of Haemophilus influenzae type b-specific antibodies.
Ojo-Amaize EA; Church JA; Barka NE; Agopian MS; Peter JB
Clin Diagn Lab Immunol; 1995 May; 2(3):286-90. PubMed ID: 7664173
[TBL] [Abstract][Full Text] [Related]
33. High antibody responses to booster doses of either Haemophilus influenzae capsular polysaccharide or conjugate vaccine after primary immunization with conjugate vaccines.
Käyhty H; Eskola J; Peltola H; Saarinen L; Mäkelä PH
J Infect Dis; 1992 Jun; 165 Suppl 1():S165-6. PubMed ID: 1588156
[No Abstract] [Full Text] [Related]
34. Use of Haemophilus polysaccharide vaccine in a rural clinic setting.
Ross SA; Darby CP; Harvell J; Watson C
J S C Med Assoc; 1988 Mar; 84(3):105-8. PubMed ID: 3258942
[No Abstract] [Full Text] [Related]
35. An idiotypic marker associated with a germ-line encoded kappa light chain variable region that predominates the vaccine-induced human antibody response to the Haemophilus influenzae b polysaccharide.
Lucas AH; Langley RJ; Granoff DM; Nahm MH; Kitamura MY; Scott MG
J Clin Invest; 1991 Dec; 88(6):1811-8. PubMed ID: 1752943
[TBL] [Abstract][Full Text] [Related]
36. The biology of Haemophilus influenzae type b vaccination failure.
Holmes SJ; Granoff DM
J Infect Dis; 1992 Jun; 165 Suppl 1():S121-8. PubMed ID: 1588145
[TBL] [Abstract][Full Text] [Related]
37. Impaired antibody response to Haemophilus influenzae type b polysaccharide and low IgG2 and IgG4 concentrations in Apache children.
Siber GR; Santosham M; Reid GR; Thompson C; Almeido-Hill J; Morell A; deLange G; Ketcham JK; Callahan EH
N Engl J Med; 1990 Nov; 323(20):1387-92. PubMed ID: 2233905
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of Haemophilus influenzae type b vaccines.
Stieb DM; Frayha HH; Oxman AD; Shannon HS; Hutchison BG; Crombie FS
CMAJ; 1990 Apr; 142(7):719-33. PubMed ID: 2107962
[TBL] [Abstract][Full Text] [Related]
39. Clinical experience with Haemophilus influenzae type b conjugate vaccines.
Mäkelä PH; Eskola J; Peltola H; Takala AK; Käyhty H
Pediatrics; 1990 Apr; 85(4 Pt 2):651-3. PubMed ID: 2179855
[TBL] [Abstract][Full Text] [Related]
40. Restricted Ig H chain V gene usage in the human antibody response to Haemophilus influenzae type b capsular polysaccharide.
Adderson EE; Shackelford PG; Quinn A; Carroll WL
J Immunol; 1991 Sep; 147(5):1667-74. PubMed ID: 1908880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
